CA
ZYME icon

Clearstead Advisors’s Zymeworks ZYME Stock Holding History

Clearstead Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,001
Closed -$85.4K – 3301
2025
Q3 		$85.4K Buy
5,001
+1
+0% +$14 ﹤0.01% 1096
2025
Q2 		$62.8K Hold
5,000
– – ﹤0.01% 1212
2025
Q1 		$59.5K Hold
5,000
– – ﹤0.01% 1130
2024
Q4 		$73.2K Hold
5,000
– – ﹤0.01% 1084
2024
Q3 		$62.8K Hold
5,000
– – ﹤0.01% 1153
2024
Q2 		$42.5K Buy
+5,000
New +$44.5K ﹤0.01% 1203

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Clearstead Advisors's ZYME Position: Q4 2025 in Review

Clearstead Advisors sold out of Zymeworks (ZYME) in Q4 2025, closing a stake of 5,001 shares — an estimated $85.4K sold.

Clearstead Advisors first reported a position in ZYME in Q2 2024 and held it in 6 quarters. The position peaked at $85.4K in Q3 2025. 209 funds tracked by Wall St. Rank hold ZYME as of Q4 2025.

  • Clearstead Advisors reported no remaining Zymeworks position as of Q4 2025 after selling out during the quarter.
  • Clearstead Advisors sold 5,001 Zymeworks shares in Q4 2025, an estimated $85.4K.
  • Clearstead Advisors first reported a position in Zymeworks in Q2 2024 and held it in 6 quarters.
  • Clearstead Advisors's Zymeworks position peaked at $85.4K in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Zymeworks as of Q4 2025.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.